Lymphoma

Bayer will work with the FDA toward voluntary withdrawal of its follicular lymphoma treatment copanlisib from the U.S. market, according to a company-issued press release.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses treatment challenges in DLBCL care.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the unmet needs of patients with DLBCL.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the challenges of researching combination therapies.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the latest advancements in the treatment of DLBCL.

In this video, Joshua Brody, MD, director of the lymphoma immunotherapy program at the Icahn School of Medicine at Mount Sinai, discusses the latest advancements in DLBCL subtying and classification.

The offspring of adolescent and young adult women with a history of cancer experienced a higher risk for birth defects, according to study results published in Cancer Epidemiology, Biomarkers & Prevention.

The FDA placed a partial clinical hold on two trials evaluating lacutamab for T-cell lymphomas after a patient died of hemophagocytic lymphohistiocytosis, according to the agent’s manufacturer.

A hematologist is a specialist in hematology, the science or study of blood, blood-forming organs and blood diseases.

Hematology is the science or study of blood and blood diseases.